• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Bristol Myers gets positive opinion from CHMP for Opdivo

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jul 24, 2023 at 10:22: AM
via Bristol Myers Squibb has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) which recommended approval on Opdivo (nivolumab) for use as an adjuvant treatment in patients with completely resected stage IIB or IIC melanoma.

article source
 




Top Bottom
Back
Quote